1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Diagnostics Focus NOVEMBER 2016

Diagnostics Focus NOVEMBER 2016

  • November 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Strong Growth In Diagnostics Will Continue
Industry Trend Analysis - Celgene Bolsters AML Compound With Diagnostic Agreement
Industry Brief - Globavir Partners Bio-Rad For Dengue Detection Technology
Industry Brief - HTG /Merck Ink Master Companion Diagnostics Pact
Industry Trend Analysis - Partnering With Quest Will Drive Watson's Adoption
Industry Brief - Zalgen/NOWDiagnostics To Co-Develop Novel RDTs For Tropical Diseases
Industry Brief - Myriad To Measure Predictive Cardiovascular Biomarkers In Sanofi Trial
Industry Brief - Definiens Enters Programme Collaboration With Takeda
Industry Brief - VolitionRx Closes Public Offering Of Common Stock
Industry Brief - Transgenomic And Precipio Diagnostics Plan To Merge
Industry Brief - Oxford Immunotec To Acquire Immunetics
Industry Brief - Renishaw To Close Diagnostics Unit
Industry Brief - RPRD Diagnostics Launched
Industry Brief - CSA Group Grants CPC Laboratory Qualification To Philips Suzhou
Industry Brief - Veritas Genetics Secures Funding
Industry Brief - Shareholders Approve Alere-Abbott Merger
Industry Brief - Sedia/Floragenex Complete Merger
Industry Brief - Regulatory Clearances Granted To Danaher's Acquisition Of Cepheid
Industry Brief - Danaher Completes Cepheid Acquisition
Industry Brief - P4 Diagnostix Laboratory Network Acquires Metamark Laboratories
Industry Brief - Chembio To Acquire Malaysia-Based RVR Diagnostics
Industry Trend Analysis - Acquisitions To Fuel Revenue Growth
Industry Trend Analysis - Quest Refocuses To Aid Long-Term Growth
Industry Brief - Diagnostics 510(k) Clearances - October 2016
Industry Brief - Abingdon Health's Seralite-FLC ELISA Granted CE Mark Approval
Industry Brief - HiberGene Meningococcus Direct Swab Test Launched In Europe
Industry Brief - Qiagen Launches QIAsymphony System Outside Of The US
Industry Brief - Arcis DNA Blood Kit Launched In UK
Industry Brief - Qiagen Launches QIAseq cfDNA All-In-One Kit
Industry Brief - HiberGene Launches HG Group B Streptococcus Direct Swab Test
Industry Brief - GeneFirst Reports CE Marking And Release Of Papilloplex HR-HPV Test
Industry Brief - FDA Approves cobas MPX Blood Screening Assay On 6800/8800 Systems
Industry Brief - FDA Grants Expanded Approval For Using Dako PD-L1 IHC 22C3 pharmDx With Keytruda
Industry Brief - FDA Approves PreciseType HEA Test To Screen Blood Donors For SCT
Industry Brief - Ortho Vision Max Analyser Granted US Marketing Clearance
Industry Brief - Solana Strep Complete Gains FDA Clearance
Industry Brief - PathoQuest Gains CE Mark For iDTECT Blood Test
Industry Brief - Roche's Ventana PD-L1 Assay FDA-Approved As Complementary Diagnostic
Industry Brief - BD MAX Vaginal Panel Granted FDA Market Authorisation
Industry Brief - Asuragen Unveils QuantideX NGS RNA LC Kit
Industry Brief - Exalenz Receives FDA Marketing Clearance For BreathID
Industry Brief - Chembio's DPP Zika Test Granted ANVISA Approval
Industry Brief - Cancer Genetics' Focus::Renal NGS Panel Approved In US
Industry Brief - UK National Screening Committee Approves NIPT For Pregnant Women
Industry Brief - Illumina Launches TruSight Tumor 170
Industry Brief - HalioDx Launches Immunoseek CR
Industry Brief - Myriad Seeks Japanese Regulatory Approval for BRACAnalysis CDx
Industry Trend Analysis - Data Released At ESMO To Increase Uptake
Industry Brief - Syros Secures FDA IDE For Blood Test With Proprietary Biomarkers
Industry Brief - Prometheus Anser VDZ Test Validated For Use With Entyvioin
Industry Brief - Arquer Diagnostics Collaborates With University of Sunderland
Industry Brief - Atomo Diagnostics Receives Grant to Develop HIV Self-Test
Industry Brief - MDNA Enters Collaboration For Non-Invasive Blood-based Endometriosis Test
Industry Brief - Biocartis Secures Grant To Support Development Of NGS Prep Panels
Industry Brief - Diagnostic Conferences - November 2016

Table Of Contents

Diagnostics Focus NOVEMBER 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.